Raising HDL cholesterol: Which is the best strategy?

被引：7

作者：

Feliciano Alfonso, John Edwin ^{[1
]}

Sierra Ariza, Ivan Dario ^{[1
]}

机构：

[1] Univ Nacl Colombia, Fac Med, Div Lipidos & Diabet, Bogota, Colombia

来源：

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA | 2008年 / 54卷 / 04期

关键词：

cholesterol HDL; smoking; statins; fibrates; rimonabant;

D O I：

10.1590/S0104-42302008000400025

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

After having reached the objective for the LDL cholesterol levels, It becomes imperative to reach the objective for HDL cholesterol, known for its anti-atherogenic properties, generally confirmed in many epidemiological studies. This review deals, in a clear and concise manner, with the different alternatives available in daily clinical practice to raise the HDL cholesterol levels of patients, to achieve better outcomes in terms of morbidity and mortality in cardiovascular disease.

引用

页码：369 / 376

页数：8

共 79 条

[1] Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol [J].

Alsheikh-Ali, Alawi A. ;

Lin, Jen-Liang ;

Abourjaily, Paul ;

Ahearn, Dineli ;

Kuvin, Jeffrey T. ;

Karas, Richard H. .

AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (10) :1499-1501

[2] The efficacy and safety of sibutramine for weight loss - A systematic review [J].

Arterburn, DE ;

Crane, PK ;

Veenstra, DL .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (09) :994-1003

[3] HDL in atherosclerosis: actor or bystander? [J].

Asztalos, BF ;

Schaefer, EJ .

ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (01) :21-29

[4]

Azizi F, 2002, NUTR METAB CARDIOVAS, V12, P80

[5] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[6] Effects of non-heavy smoking on high-density lipoprotein cholesterol in healthy Turkish young men [J].

Barcin, Cem ;

Tapan, Serkan ;

Kursaklioglu, Hurkan ;

Iyisoy, Atila ;

Olcay, Ayhan ;

Erbil, M. Kemal ;

Isik, Ersoy .

ACTA CARDIOLOGICA, 2006, 61 (04) :411-415

[7] HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events [J].

Barter, Philip ;

Gotto, Antonio M. ;

LaRosa, John C. ;

Maroni, Jaman ;

Szarek, Michael ;

Grundy, Scott M. ;

Kastelein, John J. P. ;

Bittner, Vera ;

Fruchart, Jean-Charles .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (13) :1301-1310

[8] Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds - A meta-analysis of randomized controlled trials [J].

Birjmohun, RS ;

Hutten, BA ;

Kastelein, JJP ;

Stroes, ESG .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (02) :185-197

[9] Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus [J].

Bolen, Shari ;

Feldman, Leonard ;

Vassy, Jason ;

Wilson, Lisa ;

Yeh, Hsin-Chieh ;

Marinopoulos, Spyriclon ;

Wiley, Crystal ;

Selvin, Elizabeth ;

Wilson, Renee ;

Bass, Eric B. ;

Brancati, Frederick L. .

ANNALS OF INTERNAL MEDICINE, 2007, 147 (06) :386-399

[10]

BURR ML, 1989, LANCET, V2, P757

← 1 2 3 4 5 6 7 8 →